Christy J. Oliger

CIK 1822092 · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$636.8K

Companies

8

Total Filings

27

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VERA Director $34.26 $0 3 2026-05-26
KPTI Director 15,508 $9.50 $147.3K $0 7 2026-05-26
REPL Director $8.88 $0 6 2026-04-07
LAVA Therapeutics NV (LVTX) Delisted Director $1.74 $0 2 2025-11-17
NUVL Director 3,971 $123.25 $489.4K $0 1 2025-06-20
RayzeBio, Inc. (RYZB) Delisted Director $62.49 $0 1 2024-02-27
REATA PHARMACEUTICALS INC (RETA) Delisted Director 0 $172.36 $0 $0 5 2023-09-26
Sierra Oncology, Inc. (SRRA) Delisted Director $54.99 $0 2 2022-07-01

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-04-05 REPL Grant (A) $0 EDGAR
2021-12-03 REPL Grant (A) $0 EDGAR
2021-06-14 REATA PHARMACEUTICALS INC (RETA) Delisted Grant (A) $0 EDGAR
2021-06-04 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2021-05-21 KPTI Grant (A) $0 EDGAR
2021-04-16 REATA PHARMACEUTICALS INC (RETA) Delisted Grant (A) $0 EDGAR
2020-08-31 KPTI Grant (A) $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.